ORiordan Anne

ORiordan Anne is listed in filings as Director at Jazz Pharmaceuticals PLC. This profile follows SEC Form 4 activity through Aug 11, 2025, including 4 public disclosures. Recent filings connect the profile to Jazz Pharmaceuticals PLC (JAZZ). The current snapshot covers public activity from Aug 6, 2024 to Aug 11, 2025. Reported amounts are shown as $200.8K to $165.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.